USP38 regulates inflammatory cardiac remodeling after myocardial infarction
Clinical Science · 15.11.2023 · 137 (21) · 1665-1681
DOI: 10.1042/cs20230728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 15.11.2023. Verfasst von Yang Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, Hubei 430060, China. Hauptthemen laut MEDLINE: NF-kappa B, Myocardial Infarction. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The inflammatory response and subsequent ventricular remodeling are key factors contributing to ventricular arrhythmias (VAs) after myocardial infarction (MI). Ubiquitin-specific protease 38 (USP38) is a member of the USP family, but the impact of USP38 in arrhythmia substrate generation after MI remains unclear. This study aimed to determine the role of USP38 in post-MI VAs and its underlying mechanisms. Methods and results: Surgical left descending coronary artery ligation was used to construct MI models. Morphological, biochemical, histological, and electrophysiological studies and molecular analyses were performed after MI on days 3 and 28. We found that the USP38 expression was remarkably increased after MI. Cardiac-conditional USP38 knockout (USP38-CKO) reduces the expression of the inflammatory marker CD68 as well as the inflammatory factors TNF-α and IL-1β after MI, thereby alleviating advanced cardiac fibrosis, electrical remodeling, ion channel remodeling, and susceptibility to VAs. In contrast, cardiac-specific USP38 overexpression (USP38-TG) showed a significant opposite effect, exacerbating the early inflammatory response and cardiac remodeling after MI. Mechanistically, USP38 knockout inhibited activation of the TAK1/NF-κB signaling pathway after MI, whereas USP38 overexpression enhanced activation of the TAK1/NF-κB signaling pathway after MI.
Conclusions
Our study confirms that USP38-CKO attenuates the inflammatory response, improves ventricular remodeling after myocardial infarction, and reduces susceptibility to malignant VA by inhibiting the activation of the TAK1/NF-κB pathway, with USP38-TG playing an opposing role. These results suggest that USP38 may be an important target for the treatment of cardiac remodeling and arrhythmias after MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, Hubei 430060, China.
- Cardiovascular Research Institute of Wuhan University, Wuhan, China.
- Hubei Key Laboratory of Cardiology, Wuhan, China.
ORCID-Profile: He Huang
Förderung
- MOST | National Natural Science Foundation of China
Zitieren
APA
Gong, Y., Kong, B., Shuai, W., Chen, T., Zhang, J. J., & Huang, H. (2023). USP38 regulates inflammatory cardiac remodeling after myocardial infarction. Clinical Science, 137(21), 1665-1681. https://doi.org/10.1042/cs20230728
Vancouver
Gong Y, Kong B, Shuai W, Chen T, Zhang JJ, Huang H. USP38 regulates inflammatory cardiac remodeling after myocardial infarction. Clinical Science. 2023;137(21):1665-1681. doi:10.1042/cs20230728
BibTeX
@article{Gong2023,
author = {Gong, Yang and Kong, Bin and Shuai, Wei and Chen, Tao and Zhang, Jing Jing and Huang, He},
title = {USP38 regulates inflammatory cardiac remodeling after myocardial infarction},
journal = {Clinical Science},
year = {2023},
volume = {137},
number = {21},
pages = {1665--1681},
doi = {10.1042/cs20230728}
}
EUVIMED